NO20002777D0 - FremgangsmÕte for bekjempelse av fedme - Google Patents

FremgangsmÕte for bekjempelse av fedme

Info

Publication number
NO20002777D0
NO20002777D0 NO20002777A NO20002777A NO20002777D0 NO 20002777 D0 NO20002777 D0 NO 20002777D0 NO 20002777 A NO20002777 A NO 20002777A NO 20002777 A NO20002777 A NO 20002777A NO 20002777 D0 NO20002777 D0 NO 20002777D0
Authority
NO
Norway
Prior art keywords
obesity
procedure
combating obesity
treated
diseases
Prior art date
Application number
NO20002777A
Other languages
English (en)
Other versions
NO324694B1 (no
NO20002777L (no
Inventor
Klaus Muenter
Michael Kirchengast
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NO20002777D0 publication Critical patent/NO20002777D0/no
Publication of NO20002777L publication Critical patent/NO20002777L/no
Publication of NO324694B1 publication Critical patent/NO324694B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002777A 1997-12-05 2000-05-30 Anvendelse av endotelinreseptor-antagonister for fremstilling av medikamenter for a kontrollere hyperlipidemi. NO324694B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19754082A DE19754082A1 (de) 1997-12-05 1997-12-05 Methode zur Bekämpfung der Fettleibigkeit
PCT/EP1998/007501 WO1999029308A2 (de) 1997-12-05 1998-11-21 Methode zur bekämpfung der fettleibigkeit

Publications (3)

Publication Number Publication Date
NO20002777D0 true NO20002777D0 (no) 2000-05-30
NO20002777L NO20002777L (no) 2000-06-02
NO324694B1 NO324694B1 (no) 2007-12-03

Family

ID=7850913

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20002777A NO324694B1 (no) 1997-12-05 2000-05-30 Anvendelse av endotelinreseptor-antagonister for fremstilling av medikamenter for a kontrollere hyperlipidemi.
NO20074419A NO20074419L (no) 1997-12-05 2007-08-30 Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20074419A NO20074419L (no) 1997-12-05 2007-08-30 Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom

Country Status (17)

Country Link
US (1) US6197780B1 (no)
EP (1) EP1035851B1 (no)
JP (1) JP2002512173A (no)
KR (1) KR20010032779A (no)
CN (1) CN1152685C (no)
AT (1) ATE204172T1 (no)
AU (1) AU751053B2 (no)
BR (1) BR9815335A (no)
CA (1) CA2311423C (no)
CZ (1) CZ300442B6 (no)
DE (2) DE19754082A1 (no)
ES (1) ES2162493T3 (no)
HK (1) HK1037141A1 (no)
HU (1) HUP0100171A3 (no)
NO (2) NO324694B1 (no)
RU (1) RU2292891C2 (no)
WO (1) WO1999029308A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) * 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
JP2010536880A (ja) 2007-08-22 2010-12-02 ギリード・コロラド・インコーポレーテッド 糖尿病の合併症のための療法
TWI701253B (zh) * 2011-11-11 2020-08-11 美商基利阿波羅有限責任公司 Ａｃｃ抑制劑及彼等之用途
EA201700155A1 (ru) * 2014-10-20 2017-10-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтическая композиция для лечения туберкулеза
AR106472A1 (es) 2015-10-26 2018-01-17 Gilead Apollo Llc Inhibidores de acc y usos de los mismos
KR20180082557A (ko) 2015-11-25 2018-07-18 길리어드 아폴로, 엘엘씨 트리아졸 acc 억제제 및 그의 용도
CA3004798C (en) 2015-11-25 2023-10-31 Gilead Apollo, Llc Ester acc inhibitors and uses thereof
KR20180086191A (ko) 2015-11-25 2018-07-30 길리어드 아폴로, 엘엘씨 2,4-디옥소-1,4-디히드로티에노[2,3-d]피리미딘 유도체를 함유하는 살진균 조성물
BR112018010113B1 (pt) 2015-11-25 2022-06-14 Gilead Apollo, Llc Composto de pirazol útil como inibidor da acetil-coa carboxilase (acc)
CA3220447A1 (en) 2016-03-02 2017-09-08 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
JP6906626B2 (ja) 2017-03-28 2021-07-21 ギリアード サイエンシーズ， インコーポレイテッド 肝疾患を処置するための治療的組み合わせ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0670320A4 (en) * 1992-12-01 1997-05-02 Green Cross Corp DERIVATIVE OF 1,8-NAPHTHYRIDIN-2-ONE AND USE OF THIS DERIVATIVE.
US5998468A (en) * 1995-08-24 1999-12-07 Warner-Lambert Company Furanone endothelin antagonists
JP3116347B2 (ja) * 1996-11-13 2000-12-11 田辺製薬株式会社 医薬組成物

Also Published As

Publication number Publication date
ATE204172T1 (de) 2001-09-15
RU2003138080A (ru) 2005-06-10
ES2162493T3 (es) 2001-12-16
WO1999029308A3 (de) 1999-09-30
NO20074419L (no) 2000-06-02
AU2153599A (en) 1999-06-28
CZ300442B6 (cs) 2009-05-20
AU751053B2 (en) 2002-08-08
US6197780B1 (en) 2001-03-06
DE19754082A1 (de) 1999-06-10
NO324694B1 (no) 2007-12-03
HUP0100171A2 (hu) 2003-02-28
BR9815335A (pt) 2000-10-17
HK1037141A1 (en) 2002-02-01
KR20010032779A (ko) 2001-04-25
WO1999029308A2 (de) 1999-06-17
DE59801230D1 (de) 2001-09-20
CA2311423C (en) 2008-01-29
CN1152685C (zh) 2004-06-09
CN1301162A (zh) 2001-06-27
EP1035851B1 (de) 2001-08-16
RU2292891C2 (ru) 2007-02-10
JP2002512173A (ja) 2002-04-23
CA2311423A1 (en) 1999-06-17
EP1035851A2 (de) 2000-09-20
NO20002777L (no) 2000-06-02
CZ20002006A3 (cs) 2000-11-15
HUP0100171A3 (en) 2003-10-28

Similar Documents

Publication Publication Date Title
NO20002777D0 (no) FremgangsmÕte for bekjempelse av fedme
DK1047781T3 (da) IL-18-receptorer
ES2184127T3 (es) Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad.
EP1231218A3 (en) An appetite-suppressing peptide, its compositions and use
DE69732868D1 (de) Mittel gegen Juckreiz
DK1119371T3 (da) Flt4 (VEGFR-3) som et mål for tumorbilleddannelse og antitumorterapi
DK1632234T3 (da) (S,S)-reboxetin til behandling af kronisk træthedssyndrom
CY1107829T1 (el) Νεες ενωσεις αγωνιστες εξεντινης
TR970073A2 (tr) Alfa adrenerjik resentör antagonistleri olarak pirimidindion pirimidintrion,triazindion, tetrahidrokinazolindion türevleri.
DK1094816T3 (da) Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
CL2010000375A1 (es) Compuestos mimeticos de glucocorticoides derivados de hidroxialquilo sustituidos por heterociclos; procedimiento de preparacion; composicion farmaceutica; kit farmaceutico; y uso para el tratamiento de un estado o trastorno seleccionado de diabetes tipo ii, obesidad, hipertension, entre otras (divisional de solicitud 585-03).
DE69727908D1 (de) Tumor-Nekrosis-Faktor verwandter Receptor, TR6
DE69805237D1 (de) Tumornekrose zugehöriger Rezeptor, TR4
MX225999B (es) Polimorfo antifungico cristalino.
ATE268750T1 (de) Proteintyrosinphosphatase inhibitoren
DK1383919T3 (da) Fremgangsmåder og sammensætninger til anvendelse af MHC klasse II-invariant kædepolypeptid som en receptor for makrofag migrationsinhiberede faktor
TR199600359A2 (tr) Adezyon reseptörü antagonistleri.
TR199802624A3 (tr) Yeni farmasötik.
FI970823A (fi) Uusia peptidijohdannaisia, joilla esiintyy delta-opioidireseptoreihin kohdistuvia antagonistisia vaikutuksia tai samanaikaisia my-agonistisia/delta-antagonistisia vaikutuksia
TR200001290T2 (tr) Estrojen mahrumiyet sendromunu tedavi etmek için yararlı 2-aril-3-aroilbenzo(b) tiofenler.
RU2000117857A (ru) Способ борьбы с ожирением
FI974583A0 (fi) Avvattningsfoerfarande och -element i samband med en sellulosatorkmaskin el.dyl.
ES1035823U (es) Bovedilla perfeccionada.
TR199601082A3 (tr) Entegrin reseptör antagonistleri.
IT239289Y1 (it) Lumino per sepolcri, immagini votive e simili.

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ABBVIE DEUTSCHLAND GMBH & CO AG, DE

MM1K Lapsed by not paying the annual fees